Cancer Registry Software Market Size, Share & Trends Report

Cancer Registry Software Market Size, Share & Trends Analysis Report By Software (Standalone), By Deployment model (On-premise), By Component (Commercial), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-3-68038-753-7
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cancer Registry Software Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Cancer Registry Software Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Cancer Registry Software Market: Software Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cancer Registry Software Market: Software Movement Analysis, 2023 & 2030 (USD Million)
4.3. Standalone
4.3.1. Standalone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Integrated
4.4.1. Integrated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cancer Registry Software Market: Deployment Model Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Cancer Registry Software Market: Deployment Model Movement Analysis, 2023 & 2030 (USD Million)
5.3. On-premise
5.3.1. On-premise Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Cloud Based
5.4.1. Cloud Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cancer Registry Software Market: Component Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cancer Registry Software Market: Component Movement Analysis, 2023 & 2030 (USD Million)
6.3. Commercial
6.3.1. Commercial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Public
6.4.1. Public Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Cancer Registry Software Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Cancer Registry Software Market: End-use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Government & Third Party
7.3.1. Government & Third-Party Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Private Payers
7.4.1. Private Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospital & Medical Practice
7.5.1. Hospital & Medical Practice Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Pharma Biotech & Medical Device Companies
7.6.1. Pharma Biotech & Medical Device Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Research Institutes
7.7.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Cancer Registry Software Market: Regional Estimates & Trend Analysis
8.1. Cancer Registry Software Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Cancer Registry Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Elekta
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Oracle
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. ONCO, Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. IBM
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. MCKESSON CORPORATION
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Conduent, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Ordinate Corporation
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Volpara Health Limited
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Health Catalyst
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Rocky Mountain Cancer Data Systems (RMCDS) (University of Utah Health)
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.